Last updated: 2026-09-06 11:03:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
AirSculpt Technologies, Inc. (AIRS) operates in the SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE sector and is listed on NASDAQ. The stock is currently priced at $2.80, with a market capitalization of $177.35M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $1.51 to $12.00. This page covers its latest market performance, valuation, price trends and company information.
$177.35M | |
$2.51 | |
$18.48 | |
$1.51 | |
$2.54 | |
1.53M | |
-- | |
-- | |
$12.00 | |
$1.51 | |
-- | |
-- |
AirSculpt Technologies, Inc. (AIRS) last closed at $2.54 as of 2026-09-04 23:57:00, unchanged from the previous close of $2.54.
During the latest regular trading session, AIRS traded between $1.51 and $18.48, with a volume of 1.53M shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, AirSculpt Technologies, Inc. (AIRS) moved from $2.54 to $2.80, representing a gain of 10.04% ($0.25).
The stock traded between $2.48 and $2.87 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 884.86 thousand shares, up versus the previous seven-day period, indicating higher trading activity.
Position in Range: 12.2%
AIRS is currently trading at $2.80, placing it 12.2% of the way from its 52-week low of $1.51 to its 52-week high of $12.00. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
AirSculpt Technologies Inc is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results. Its proprietary and patented AirSculpt method is minimally invasive because it requires no needle, no scalpel, no stitches, and no general anesthesia. It offers fat removal procedures across treatment areas and fat transfer procedures that use the patient's own fat cells to enhance the breasts, buttocks, hips or other areas and do not require silicone or foreign materials to be implanted. Its segment is direct medical procedure services.
| Industry | SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE |
| Employees | 363 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of AirSculpt Technologies, Inc. (AIRS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.